NL8101191A - Oxytocine derivaat; farmaceutisch preparaat; werkwijze voor het tegengaan van spiercontracties van de uterus. - Google Patents

Oxytocine derivaat; farmaceutisch preparaat; werkwijze voor het tegengaan van spiercontracties van de uterus. Download PDF

Info

Publication number
NL8101191A
NL8101191A NL8101191A NL8101191A NL8101191A NL 8101191 A NL8101191 A NL 8101191A NL 8101191 A NL8101191 A NL 8101191A NL 8101191 A NL8101191 A NL 8101191A NL 8101191 A NL8101191 A NL 8101191A
Authority
NL
Netherlands
Prior art keywords
oxytocin
uterus
derivative
pharmaceutical composition
uterine
Prior art date
Application number
NL8101191A
Other languages
English (en)
Dutch (nl)
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Publication of NL8101191A publication Critical patent/NL8101191A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8101191A 1980-03-24 1981-03-11 Oxytocine derivaat; farmaceutisch preparaat; werkwijze voor het tegengaan van spiercontracties van de uterus. NL8101191A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8002222A SE430885B (sv) 1980-03-24 1980-03-24 Oxytocin-derivat
SE8002222 1980-03-24

Publications (1)

Publication Number Publication Date
NL8101191A true NL8101191A (nl) 1981-10-16

Family

ID=20340577

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8101191A NL8101191A (nl) 1980-03-24 1981-03-11 Oxytocine derivaat; farmaceutisch preparaat; werkwijze voor het tegengaan van spiercontracties van de uterus.

Country Status (10)

Country Link
US (1) US4402942A (it)
JP (1) JPS56150050A (it)
BE (1) BE887970A (it)
CH (1) CH646139A5 (it)
DE (1) DE3108323C2 (it)
FR (1) FR2482093A1 (it)
GB (1) GB2074582B (it)
IT (1) IT1136574B (it)
NL (1) NL8101191A (it)
SE (1) SE430885B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7722733B2 (en) 2004-03-29 2010-05-25 Baxter International Inc. Method for sterile connection of tubing

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504469A (en) * 1982-12-21 1985-03-12 Ferring Ab Vasotocin derivatives
SE8207277L (sv) * 1982-12-21 1984-06-22 Ferring Ab Vasotocin-derivat
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
US4624943A (en) * 1985-03-20 1986-11-25 Smithkline Beckman Corporation Aromatic basic-tailed vasopressin antagonists
US5225528A (en) * 1990-02-27 1993-07-06 Merck & Co., Inc. Cyclic hexapeptide oxytocin antagonists
DE4042008A1 (de) * 1990-12-22 1992-06-25 Schering Ag Vasopressin-derivate
US5830848A (en) * 1992-10-09 1998-11-03 The Regents Of The University Of California Method and agents for inducement of endogenous nitric oxide synthase for control and management of labor during pregnancy
US6933417B1 (en) 1999-11-22 2005-08-23 Dow Global Technologies Inc. Process for vinyl chloride manufacture from ethane and ethylene with partial CHl recovery from reactor effluent
US6797845B1 (en) 1999-11-22 2004-09-28 Dow Global Technologies Inc. Process for vinyl chloride manufacture from ethane and ethylene with immediate HCl recovery from reactor effluent
US6909024B1 (en) * 1999-11-22 2005-06-21 The Dow Chemical Company Process for the conversion of ethylene to vinyl chloride and novel catalyst compositions useful for such process
US6680415B1 (en) * 1999-11-22 2004-01-20 Dow Global Technologies Inc. Oxyhalogenation process using catalyst having porous rare earth halide support
SE0100684D0 (sv) * 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
CA2448500C (en) * 2001-05-23 2009-11-17 Dow Global Technologies Inc. Oxidative halogenation and optional dehydrogenation of c3+ hydrocarbons
US20040152929A1 (en) * 2002-05-08 2004-08-05 Clarke William D Process for vinyl chloride manufacture from ethane and ethylene with air feed and alternative hcl processing methods
TWI463990B (zh) * 2009-09-21 2014-12-11 Ferring Bv 催產素受體促進劑
WO2016067252A1 (en) 2014-10-31 2016-05-06 Glaxosmithkline Intellectual Property Development Limited Powder formulation
AU2017205670B2 (en) 2016-01-04 2021-05-20 Merck Serono S.A. L-valinate of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
WO2018015497A2 (en) 2016-07-21 2018-01-25 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
WO2020137880A1 (ja) * 2018-12-27 2020-07-02 国立大学法人北海道大学 オキシトシン誘導体及びその使用
CA3149898A1 (en) 2019-09-03 2021-03-11 Ernest Loumaye Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
CA3167121A1 (en) 2020-02-10 2021-08-19 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy
US20240024294A1 (en) 2020-11-16 2024-01-25 Xoma (Us) Llc Compositions and methods for the treatment or prevention of preterm labor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1463865A (fr) * 1964-07-27 1966-07-22 Ceskoslovenska Akademie Ved Procédé pour la préparation des dérivés cycliques de peptides ainsi que les produits conformes à ceux obtenus par le présent procédé ou procédé similaire
CS194980B1 (en) * 1976-07-16 1979-12-31 Joseph H Cort Agent for current induction,fertilization facilitating and milkability increasing at mammals,especially at utility cattle

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7722733B2 (en) 2004-03-29 2010-05-25 Baxter International Inc. Method for sterile connection of tubing
US8162021B2 (en) 2004-03-29 2012-04-24 Baxter International Apparatus for sterile connection of tubing

Also Published As

Publication number Publication date
CH646139A5 (de) 1984-11-15
US4402942A (en) 1983-09-06
SE430885B (sv) 1983-12-19
DE3108323C2 (de) 1983-11-24
JPS56150050A (en) 1981-11-20
BE887970A (fr) 1981-07-16
FR2482093B1 (it) 1984-11-09
SE8002222L (sv) 1981-09-25
GB2074582B (en) 1983-07-06
FR2482093A1 (fr) 1981-11-13
IT8120684A0 (it) 1981-03-24
IT1136574B (it) 1986-09-03
GB2074582A (en) 1981-11-04
DE3108323A1 (de) 1981-12-24

Similar Documents

Publication Publication Date Title
NL8101191A (nl) Oxytocine derivaat; farmaceutisch preparaat; werkwijze voor het tegengaan van spiercontracties van de uterus.
US6569845B1 (en) Neovascularization inhibitor containing dienogest as the active ingredient
KR20010013712A (ko) 수용성 케토프로펜 염을 함유하는 약학적 제제 및 그의 용도
EP2552470B1 (en) Peptides for promoting angiogenesis and an use thereof
JP7126270B2 (ja) Ｎｐｒａアゴニスト、組成物およびその使用
KR20180052642A (ko) 장시간 작용형 아드레노메둘린 유도체
EP0112809A1 (en) Vasotocin derivatives
KR0124817B1 (ko) 4-퀴놀린 카복실산 유도체를 포함하는 피부 및 점막-상피성 질환 치료용 약제학적 조성물
Melin et al. Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity
CA2066155A1 (en) Antiviral agent for human immunodeficiency virus
CA2072253A1 (en) Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
KR100244624B1 (ko) 황체 형성 호르몬 방출 호르몬(lhrh) 길항제 및 이를 함유하는 약제학적 조성물
HU202754B (en) Process for producing flavoxate derivatives and pharmaceutical compositions containing them as active components
US4599331A (en) Etianic acids as antiangiogenics
Bache et al. Effects of atrial natriuretic peptide in the canine coronary circulation.
EP0005015A1 (en) Use of a xanthine derivate in the manufacture of a medicament
EP0650723A2 (en) Novel pharmaceutical use of forskolin derivatives
Su Cell protection mechanism of antishock action of anisodamine
EP0005074A1 (en) A material and composition for reducing blood pressure
US6306845B1 (en) Method for treating demyelinating disease
IE912378A1 (en) Derivatives of pituitary posterior lobe hormones
JP2002502399A (ja) プライマー化合物による抗癌剤の固形癌への増強された送達
US4956344A (en) Method for treatment of lesions in the large intestinal epithelium with a tripeptide
EP0394283B1 (en) Use of a tripeptide for the preparation of pharmaceutical compositions and a pharmaceutical composition and method
WO2023050037A1 (zh) 一种胞外亲环素抑制剂及其应用

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed